Dataset Information

Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes.

ABSTRACT:

Background

Inclusion of 12-lead electrocardiography (ECG) in preparticipation screening of young athletes is controversial because of concerns about cost-effectiveness.

Objective

To evaluate the cost-effectiveness of ECG plus cardiovascular-focused history and physical examination compared with cardiovascular-focused history and physical examination alone for preparticipation screening.

Design

Decision-analysis, cost-effectiveness model.

Data sources

Published epidemiologic and preparticipation screening data, vital statistics, and other publicly available data.

Target population

Competitive athletes in high school and college aged 14 to 22 years.

Time horizon

Lifetime.

Perspective

Societal.

Intervention

Nonparticipation in competitive athletic activity and disease-specific treatment for identified athletes with heart disease.

Outcome measure

Incremental health care cost per life-year gained.

Results of base-case analysis

Addition of ECG to preparticipation screening saves 2.06 life-years per 1000 athletes at an incremental total cost of $89 per athlete and yields a cost-effectiveness ratio of $42 900 per life-year saved (95% CI, $21 200 to $71 300 per life-year saved) compared with cardiovascular-focused history and physical examination alone. Compared with no screening, ECG plus cardiovascular-focused history and physical examination saves 2.6 life-years per 1000 athletes screened and costs $199 per athlete, yielding a cost-effectiveness ratio of $76 100 per life-year saved ($62 400 to $130 000).

Results of sensitivity analysis

Results are sensitive to the relative risk reduction associated with nonparticipation and the cost of initial screening.

Limitations

Effectiveness data are derived from 1 major European study. Patterns of causes of sudden death may vary among countries.

Conclusion

Screening young athletes with 12-lead ECG plus cardiovascular-focused history and physical examination may be cost-effective.

Primary funding source

Stanford Cardiovascular Institute and the Breetwor Foundation.

SUBMITTER: Wheeler MT

PROVIDER: S-EPMC2873148 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:BackgroundAnterior cruciate ligament (ACL) injuries are common among young athletes. Biomechanical studies have led to the development of training programs to improve neuromuscular control and reduce ACL injury rates as well as screening tools to identify athletes at higher risk for ACL injury. The purpose of this study was to evaluate the cost-effectiveness of these training methods and screening strategies for preventing ACL injuries.MethodsA decision-analysis model was created to evaluate three strategies for a population of young athletes participating in organized sports: (1) no training or screening, (2) universal neuromuscular training, and (3) universal screening, with neuromuscular training for identified high-risk athletes only. Risk of injury, risk reduction from training, and sensitivity and specificity of screening were based on published data from clinical trials. Costs of training and screening programs were estimated on the basis of the literature. Sensitivity analyses were performed on key model parameters to evaluate their effect on base case conclusions.ResultsUniversal neuromuscular training of all athletes was the dominant strategy, with better outcomes and lower costs compared with screening. On average, the implementation of a universal training program would save $100 per player per season, and would reduce the incidence of ACL injury from 3% to 1.1% per season. Screening was not cost-effective within the range of reported sensitivity and specificity values.Conclusions and clinical relevanceGiven its low cost and ease of implementation, neuromuscular training of all young athletes represents a cost-effective strategy for reducing costs and morbidity from ACL injuries. While continued innovations on inexpensive and accurate screening methods to identify high-risk athletes remain of interest, improving existing training protocols and implementing neuromuscular training into routine training for all young athletes is warranted.